Verastem, Inc. (VSTM) Financials
VSTM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 176.2 million | 71.8 million |
2023-06-30 | 191.8 million | 69.0 million |
2023-03-31 | 120.9 million | 66.7 million |
2022-12-31 | 95.1 million | 47.7 million |
VSTM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -16.6 million | 1.5 million |
2023-06-30 | -19.9 million | 1.4 million |
2023-03-31 | -20.3 million | 1.3 million |
2022-12-31 | -16.6 million | 1.3 million |
VSTM Net Income
No data available :(
VSTM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 165.7 million | - | 1.7 million |
2023-06-30 | 183.1 million | 39.7 million | 1.9 million |
2023-03-31 | 111.2 million | 39.6 million | 2.1 million |
2022-12-31 | 87.9 million | 24.5 million | 2.3 million |
VSTM Shares Outstanding
VSTM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 13.9 million | 7.4 million | - |
2023-06-30 | - | 12.9 million | 7.4 million | - |
2023-03-31 | - | 12.0 million | 7.3 million | - |
2022-12-31 | - | 10.7 million | 6.1 million | - |
VSTM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 5000 |
2023-06-30 | - | 22000 |
2023-03-31 | - | 30000 |
2022-12-31 | 2.6 million | 29000 |
VSTM
Price: $10.90
52 week price:
Earnings Per Share: -3.96 USD
P/E Ratio: -3.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 245000
Ebitda: -22.9 millionMarket Capitalization: 297.0 million